Form 4: iRhythm Technologies Executive Acquires Shares Through Employee Stock Purchase Plan

Sentiment:

Insider Transaction Report


Minang Turakhia, EVP, CMO & CSO of iRhythm Technologies, Inc., has acquired 318 shares of common stock at $74.72 per share through the company's Employee Stock Purchase Plan.

Summary

  • Minang Turakhia, Executive Vice President, Chief Marketing Officer, and Chief Strategy Officer of iRhythm Technologies, Inc. (IRTC), acquired 318 shares of the company's common stock.
  • The acquisition occurred on May 30, 2025, at a price of $74.72 per share.
  • This transaction was made pursuant to the Issuer's 2016 Employee Stock Purchase Plan (ESPP) for the purchase period from December 1, 2024, through May 31, 2025.
  • Following this acquisition, Mr. Turakhia directly beneficially owns a total of 42,813 shares of iRhythm Technologies common stock.
  • The transaction is exempt from Section 16(b) under Rule 16b-3 of the Securities Exchange Act of 1934.

Sentiment

Score: 6

Explanation: The sentiment is mildly positive as it indicates an executive's continued participation and investment in the company through a standard employee benefit program, which can be seen as a sign of confidence.

Positives

  • The acquisition of shares by a senior executive, even through an ESPP, can signal confidence in the company's future prospects and align management's interests with those of shareholders.
  • Participation in the Employee Stock Purchase Plan indicates a commitment by the executive to long-term ownership in the company.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future outlook.

Management Comments

  • Minang Turakhia is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the Issuer's 2016 Employee Stock Purchase Plan for the purchase period December 1, 2024 through May 31, 2025.

Industry Context

This filing is a routine disclosure of an insider stock transaction, specifically an acquisition through an Employee Stock Purchase Plan. It does not provide broader industry context or trends, but it is common for executives in the medical technology and healthcare diagnostics industry to participate in such plans.

Related Party Transactions

  • The acquisition of shares by Minang Turakhia through the company's 2016 Employee Stock Purchase Plan constitutes a related-party transaction, as it involves a transaction between the company and one of its executives. However, such transactions under a broad-based employee plan are generally considered standard and not problematic.

Stakeholder Impact

  • Shareholders: The increase in executive ownership, even through an ESPP, can be viewed positively as it aligns management's interests with those of shareholders.
  • Employees: The transaction highlights the existence and utilization of an Employee Stock Purchase Plan, which is a benefit for employees.

Key Dates

DateDescription
12/01/2024Start of the Employee Stock Purchase Plan period during which shares were acquired.
05/30/2025Transaction date for the acquisition of 318 shares of common stock by Minang Turakhia.
05/31/2025End of the Employee Stock Purchase Plan period during which shares were acquired.
06/03/2025Date the Form 4 filing was signed by the attorney-in-fact for Minang Turakhia.

Keywords

iRhythm Technologies, IRTC, Minang Turakhia, SEC Form 4, Insider Trading, Stock Purchase, Employee Stock Purchase Plan, ESPP, Common Stock, Executive Compensation

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.